Search

Your search keyword '"Vitreoretinopathy, Proliferative etiology"' showing total 346 results

Search Constraints

Start Over You searched for: Descriptor "Vitreoretinopathy, Proliferative etiology" Remove constraint Descriptor: "Vitreoretinopathy, Proliferative etiology"
346 results on '"Vitreoretinopathy, Proliferative etiology"'

Search Results

301. The natural history of untreated rhegmatogenous retinal detachment.

302. [Surgical management of complete macular foramina].

303. Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

304. CD 95 expression in traumatic proliferative vitreoretinopathy: a target for the induction of apoptosis.

305. Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

306. Diabetic eye complications in a medium sized municipality in southwest Norway.

307. [Modeling of vitreoretinal proliferation].

308. Rhegmatogenous retinal detachments in HIV-positive patients with ocular syphilis.

309. Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

310. Partial laser ablation of massive peripapillary subretinal neovascularization.

311. [Pathological examination of 10 eyes with silicone oil injection].

312. Aspirin is a hazard for vitreoretinal surgery.

313. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.

314. [Clinico-immunological studies in dystrophic retinal detachment complicated by proliferative vitreoretinopathy].

315. Partial characterization of a putative new growth factor present in pathological human vitreous.

316. Vascular consequences of retinectomy.

317. [Surgery in the macular foramen--pro and contra].

318. [Has the incidence of postoperative PVR in rhegmatogenous retinal detachment decreased?].

319. Retinal detachment after clear lens extraction in 41 eyes with high axial myopia.

320. Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group.

321. [Treatment of vitreoretinal proliferation in rhegmatogenous detachment and silicone oil tamponade].

322. [Risk factors of postoperative proliferative vitreoretinopathy in giant tears].

323. -Choroidal detachment associated with rhegmatogenous retinal detachment: a risk factor for postoperative PVR?.

324. [Retinal detachment with vitreous hemorrhage].

325. Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications.

326. Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR.

327. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease.

328. Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy.

329. Risk factors for proliferative vitreoretinopathy.

330. [Morphological features of vitreoretinal proliferation, complicating dystrophic retinal detachment and experimental models].

331. [Recent vitrectomy indications].

332. [Vitreoretinal proliferation as a cause of tractional retinal ablation after severe perforating injury].

333. Vitrectomy in ocular trauma.

334. Analysis of glycosaminoglycans of subretinal fluid in rhegmatogenous retinal detachment--preliminary report.

335. [Risk factors for surgical failures in rhegmatogenous retinal detachment].

336. [Current views on the etiopathogenesis of proliferative vitreoretinopathy].

337. Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes.

338. Evaluating for vitreous surgery used in proliferative vitreoretinopathy grade D3.

339. Experimental perforating injury with high energy electrons to inhibit intraocular proliferation.

340. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.

341. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery.

342. Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases.

343. The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy.

344. Immunohistochemistry of cellular proliferation in eyes with longstanding retinal detachment.

345. [Vitreoretinal proliferation. II. Pathogenic hypotheses].

346. [Horseshoe tears and proliferative vitreoretinopathy].

Catalog

Books, media, physical & digital resources